Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Izen Forte
- Development stage
- Unknown
- Lead developer
- Exeltis
- Administration
- Oral
01
Overview
Izen Forte is an oral nutraceutical supplement developed by Ordain Health Care (a subsidiary of Exeltis India) specifically formulated to support eye health and manage ophthalmic conditions such as dry eyes, age-related macular degeneration, and retinopathy. The formulation contains a synergistic blend of antioxidants, vitamins, minerals, and carotenoids, including lutein, zeaxanthin, resveratrol, omega-3 fatty acids, beta-carotene, vitamin C, vitamin D3, zinc, copper, manganese, and selenium. These active ingredients work together to protect retinal cells from oxidative stress, reduce ocular inflammation, support ocular blood flow, and filter harmful blue light, thereby promoting overall healthy vision and delaying age-related vision decline.
- Brand names
- Izen Forte
Beyond the preview
Go deeper on Izen Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Izen Forte.